P4ML P4ML is a healthtech company whose world-class proprietary analytical capabilities are set to change the way care is delivered to patients with the rarest of diseases.
You're reading Entrepreneur Middle East, an international franchise of Entrepreneur Media.
P4ML is the first multi omics solution provider, which utilizes deep learning to identify rare diseases in a day. Its mission is also to accelerate orphan drug development during newborn screening, as well as inborn errors of metabolism screening. P4ML's Data Driven Health Intelligence platform further aggregates data from multiple omics sources, and uses advanced machine learning algorithms to inform diagnosis, prognosis, therapy selection, and drug development. Comprehensive and integrated diagnostics are set to play an increasingly important role in ensuring patients receive the right treatment at the right time, and so, distinctive analytical capabilities to integrate and interpret disparate datasets, which encompasses P4ML's offering, will thus become a competitive advantage.
- FOUNDED IN: 2023
- SECTOR: HEALTHTECH
"P4ML has a mantra of employing strong PhD graduates to our entity. A key focused program from P4ML will be to engage Ireland and the United Arab Emirates on a knowledge economy, and foster local Emirati graduates."
Click here to see the full Future 100 list.
